Baidu
map

Hypertension:无人监护血压测量未增强对靶器官损害的预测性

2019-03-09 国际循环编辑部 国际循环

临床有观点认为,无人监护自动振荡测得的血压值可能比传统方式测得的血压更可信。某些国际准则甚至建议,将自动振荡血压测定作为测量血压的首选方法。与用标准测量方法相比,关于无人监护自动振荡血压与心血管事件相关性的研究非常有限。近期,Hypertension杂志发表相关研究报告。

临床有观点认为,无人监护自动振荡测得的血压值可能比传统方式测得的血压更可信。某些国际准则甚至建议,将自动振荡血压测定作为测量血压的首选方法。与用标准测量方法相比,关于无人监护自动振荡血压与血管事件相关性的研究非常有限。近期,Hypertension杂志发表相关研究报告。

该研究初步数据表明,与标准方法所得血压相比,自动振荡血压的可信性较低,同时与患者器官损伤之间相关性较大。该研究旨在评估在欧洲高血压中心接受超声心动图和颈动脉超声检查的564例患者中,无人监护血压测量或有人监护血压测量同血压与器官损害之间的关系。在超声检查的同一天,用同一台仪器随机行无人监护血压测量(患者单独在房间里,程序设定为共测量3次血压,在启动5分钟后每隔1分钟测量1次)和有人监护血压测量。结果显示,564例患者(61岁±15岁,41%为女性,78%为高血压患者)中,收缩期无监护血压测量值低于有监护血压测量值(128.0±15.5 vs. 134.5±19.9 mm Hg),左室质量指数与有人监护和无人监护收缩压的测量值相关性相近(分别为r=0.205,r=0.194)。颈动脉内膜-中膜厚度与有人监护和无人监护收缩压的测量值均显著相关(平均最大内膜-中膜厚度分别为r=0.206,r=0.194,P<0.0001)。

研究人员认为,有人监护和无人监护所测得的血压值与高血压患者器官损害的相关性相似,二者差异并无统计学意义。

原始出处:
Massimo Salvetti, Anna Paini, et al. Unattended Versus Attended Blood Pressure Measurement: Relationship With Preclinical Organ Damage. Hypertension. Jan 2019;73:736–742.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1727925, encodeId=ca571e2792545, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Tue Apr 02 20:14:00 CST 2019, time=2019-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1679370, encodeId=9e1f16e937040, content=<a href='/topic/show?id=c0ee889564a' target=_blank style='color:#2F92EE;'>#血压测量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88956, encryptionId=c0ee889564a, topicName=血压测量)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47e127763663, createdName=zxxiang, createdTime=Fri Jun 21 01:14:00 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2078443, encodeId=4c1b20e844371, content=<a href='/topic/show?id=4d92999582c' target=_blank style='color:#2F92EE;'>#靶器官#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99958, encryptionId=4d92999582c, topicName=靶器官)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19c567, createdName=habb, createdTime=Sun May 19 20:14:00 CST 2019, time=2019-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1693913, encodeId=5f321693913c6, content=<a href='/topic/show?id=48a140299ae' target=_blank style='color:#2F92EE;'>#器官损害#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40299, encryptionId=48a140299ae, topicName=器官损害)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdcd29484210, createdName=lujian, createdTime=Thu Jul 04 10:14:00 CST 2019, time=2019-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2039040, encodeId=388b2039040ee, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Wed Dec 04 09:14:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1501359, encodeId=7c181501359eb, content=<a href='/topic/show?id=f2db9238f9' target=_blank style='color:#2F92EE;'>#Hypertension#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9238, encryptionId=f2db9238f9, topicName=Hypertension)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Mon Mar 11 02:14:00 CST 2019, time=2019-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1551149, encodeId=f2ec155114977, content=<a href='/topic/show?id=e2c1e230796' target=_blank style='color:#2F92EE;'>#监护#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72307, encryptionId=e2c1e230796, topicName=监护)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=477814173963, createdName=bioon6, createdTime=Mon Mar 11 02:14:00 CST 2019, time=2019-03-11, status=1, ipAttribution=)]
    2019-04-02 feather89
  2. [GetPortalCommentsPageByObjectIdResponse(id=1727925, encodeId=ca571e2792545, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Tue Apr 02 20:14:00 CST 2019, time=2019-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1679370, encodeId=9e1f16e937040, content=<a href='/topic/show?id=c0ee889564a' target=_blank style='color:#2F92EE;'>#血压测量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88956, encryptionId=c0ee889564a, topicName=血压测量)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47e127763663, createdName=zxxiang, createdTime=Fri Jun 21 01:14:00 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2078443, encodeId=4c1b20e844371, content=<a href='/topic/show?id=4d92999582c' target=_blank style='color:#2F92EE;'>#靶器官#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99958, encryptionId=4d92999582c, topicName=靶器官)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19c567, createdName=habb, createdTime=Sun May 19 20:14:00 CST 2019, time=2019-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1693913, encodeId=5f321693913c6, content=<a href='/topic/show?id=48a140299ae' target=_blank style='color:#2F92EE;'>#器官损害#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40299, encryptionId=48a140299ae, topicName=器官损害)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdcd29484210, createdName=lujian, createdTime=Thu Jul 04 10:14:00 CST 2019, time=2019-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2039040, encodeId=388b2039040ee, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Wed Dec 04 09:14:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1501359, encodeId=7c181501359eb, content=<a href='/topic/show?id=f2db9238f9' target=_blank style='color:#2F92EE;'>#Hypertension#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9238, encryptionId=f2db9238f9, topicName=Hypertension)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Mon Mar 11 02:14:00 CST 2019, time=2019-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1551149, encodeId=f2ec155114977, content=<a href='/topic/show?id=e2c1e230796' target=_blank style='color:#2F92EE;'>#监护#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72307, encryptionId=e2c1e230796, topicName=监护)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=477814173963, createdName=bioon6, createdTime=Mon Mar 11 02:14:00 CST 2019, time=2019-03-11, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1727925, encodeId=ca571e2792545, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Tue Apr 02 20:14:00 CST 2019, time=2019-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1679370, encodeId=9e1f16e937040, content=<a href='/topic/show?id=c0ee889564a' target=_blank style='color:#2F92EE;'>#血压测量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88956, encryptionId=c0ee889564a, topicName=血压测量)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47e127763663, createdName=zxxiang, createdTime=Fri Jun 21 01:14:00 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2078443, encodeId=4c1b20e844371, content=<a href='/topic/show?id=4d92999582c' target=_blank style='color:#2F92EE;'>#靶器官#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99958, encryptionId=4d92999582c, topicName=靶器官)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19c567, createdName=habb, createdTime=Sun May 19 20:14:00 CST 2019, time=2019-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1693913, encodeId=5f321693913c6, content=<a href='/topic/show?id=48a140299ae' target=_blank style='color:#2F92EE;'>#器官损害#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40299, encryptionId=48a140299ae, topicName=器官损害)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdcd29484210, createdName=lujian, createdTime=Thu Jul 04 10:14:00 CST 2019, time=2019-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2039040, encodeId=388b2039040ee, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Wed Dec 04 09:14:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1501359, encodeId=7c181501359eb, content=<a href='/topic/show?id=f2db9238f9' target=_blank style='color:#2F92EE;'>#Hypertension#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9238, encryptionId=f2db9238f9, topicName=Hypertension)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Mon Mar 11 02:14:00 CST 2019, time=2019-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1551149, encodeId=f2ec155114977, content=<a href='/topic/show?id=e2c1e230796' target=_blank style='color:#2F92EE;'>#监护#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72307, encryptionId=e2c1e230796, topicName=监护)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=477814173963, createdName=bioon6, createdTime=Mon Mar 11 02:14:00 CST 2019, time=2019-03-11, status=1, ipAttribution=)]
    2019-05-19 habb
  4. [GetPortalCommentsPageByObjectIdResponse(id=1727925, encodeId=ca571e2792545, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Tue Apr 02 20:14:00 CST 2019, time=2019-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1679370, encodeId=9e1f16e937040, content=<a href='/topic/show?id=c0ee889564a' target=_blank style='color:#2F92EE;'>#血压测量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88956, encryptionId=c0ee889564a, topicName=血压测量)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47e127763663, createdName=zxxiang, createdTime=Fri Jun 21 01:14:00 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2078443, encodeId=4c1b20e844371, content=<a href='/topic/show?id=4d92999582c' target=_blank style='color:#2F92EE;'>#靶器官#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99958, encryptionId=4d92999582c, topicName=靶器官)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19c567, createdName=habb, createdTime=Sun May 19 20:14:00 CST 2019, time=2019-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1693913, encodeId=5f321693913c6, content=<a href='/topic/show?id=48a140299ae' target=_blank style='color:#2F92EE;'>#器官损害#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40299, encryptionId=48a140299ae, topicName=器官损害)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdcd29484210, createdName=lujian, createdTime=Thu Jul 04 10:14:00 CST 2019, time=2019-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2039040, encodeId=388b2039040ee, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Wed Dec 04 09:14:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1501359, encodeId=7c181501359eb, content=<a href='/topic/show?id=f2db9238f9' target=_blank style='color:#2F92EE;'>#Hypertension#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9238, encryptionId=f2db9238f9, topicName=Hypertension)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Mon Mar 11 02:14:00 CST 2019, time=2019-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1551149, encodeId=f2ec155114977, content=<a href='/topic/show?id=e2c1e230796' target=_blank style='color:#2F92EE;'>#监护#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72307, encryptionId=e2c1e230796, topicName=监护)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=477814173963, createdName=bioon6, createdTime=Mon Mar 11 02:14:00 CST 2019, time=2019-03-11, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1727925, encodeId=ca571e2792545, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Tue Apr 02 20:14:00 CST 2019, time=2019-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1679370, encodeId=9e1f16e937040, content=<a href='/topic/show?id=c0ee889564a' target=_blank style='color:#2F92EE;'>#血压测量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88956, encryptionId=c0ee889564a, topicName=血压测量)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47e127763663, createdName=zxxiang, createdTime=Fri Jun 21 01:14:00 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2078443, encodeId=4c1b20e844371, content=<a href='/topic/show?id=4d92999582c' target=_blank style='color:#2F92EE;'>#靶器官#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99958, encryptionId=4d92999582c, topicName=靶器官)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19c567, createdName=habb, createdTime=Sun May 19 20:14:00 CST 2019, time=2019-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1693913, encodeId=5f321693913c6, content=<a href='/topic/show?id=48a140299ae' target=_blank style='color:#2F92EE;'>#器官损害#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40299, encryptionId=48a140299ae, topicName=器官损害)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdcd29484210, createdName=lujian, createdTime=Thu Jul 04 10:14:00 CST 2019, time=2019-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2039040, encodeId=388b2039040ee, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Wed Dec 04 09:14:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1501359, encodeId=7c181501359eb, content=<a href='/topic/show?id=f2db9238f9' target=_blank style='color:#2F92EE;'>#Hypertension#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9238, encryptionId=f2db9238f9, topicName=Hypertension)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Mon Mar 11 02:14:00 CST 2019, time=2019-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1551149, encodeId=f2ec155114977, content=<a href='/topic/show?id=e2c1e230796' target=_blank style='color:#2F92EE;'>#监护#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72307, encryptionId=e2c1e230796, topicName=监护)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=477814173963, createdName=bioon6, createdTime=Mon Mar 11 02:14:00 CST 2019, time=2019-03-11, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1727925, encodeId=ca571e2792545, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Tue Apr 02 20:14:00 CST 2019, time=2019-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1679370, encodeId=9e1f16e937040, content=<a href='/topic/show?id=c0ee889564a' target=_blank style='color:#2F92EE;'>#血压测量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88956, encryptionId=c0ee889564a, topicName=血压测量)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47e127763663, createdName=zxxiang, createdTime=Fri Jun 21 01:14:00 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2078443, encodeId=4c1b20e844371, content=<a href='/topic/show?id=4d92999582c' target=_blank style='color:#2F92EE;'>#靶器官#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99958, encryptionId=4d92999582c, topicName=靶器官)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19c567, createdName=habb, createdTime=Sun May 19 20:14:00 CST 2019, time=2019-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1693913, encodeId=5f321693913c6, content=<a href='/topic/show?id=48a140299ae' target=_blank style='color:#2F92EE;'>#器官损害#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40299, encryptionId=48a140299ae, topicName=器官损害)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdcd29484210, createdName=lujian, createdTime=Thu Jul 04 10:14:00 CST 2019, time=2019-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2039040, encodeId=388b2039040ee, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Wed Dec 04 09:14:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1501359, encodeId=7c181501359eb, content=<a href='/topic/show?id=f2db9238f9' target=_blank style='color:#2F92EE;'>#Hypertension#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9238, encryptionId=f2db9238f9, topicName=Hypertension)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Mon Mar 11 02:14:00 CST 2019, time=2019-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1551149, encodeId=f2ec155114977, content=<a href='/topic/show?id=e2c1e230796' target=_blank style='color:#2F92EE;'>#监护#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72307, encryptionId=e2c1e230796, topicName=监护)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=477814173963, createdName=bioon6, createdTime=Mon Mar 11 02:14:00 CST 2019, time=2019-03-11, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1727925, encodeId=ca571e2792545, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Tue Apr 02 20:14:00 CST 2019, time=2019-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1679370, encodeId=9e1f16e937040, content=<a href='/topic/show?id=c0ee889564a' target=_blank style='color:#2F92EE;'>#血压测量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88956, encryptionId=c0ee889564a, topicName=血压测量)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47e127763663, createdName=zxxiang, createdTime=Fri Jun 21 01:14:00 CST 2019, time=2019-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2078443, encodeId=4c1b20e844371, content=<a href='/topic/show?id=4d92999582c' target=_blank style='color:#2F92EE;'>#靶器官#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99958, encryptionId=4d92999582c, topicName=靶器官)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19c567, createdName=habb, createdTime=Sun May 19 20:14:00 CST 2019, time=2019-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1693913, encodeId=5f321693913c6, content=<a href='/topic/show?id=48a140299ae' target=_blank style='color:#2F92EE;'>#器官损害#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40299, encryptionId=48a140299ae, topicName=器官损害)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fdcd29484210, createdName=lujian, createdTime=Thu Jul 04 10:14:00 CST 2019, time=2019-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2039040, encodeId=388b2039040ee, content=<a href='/topic/show?id=b45d1e274e8' target=_blank style='color:#2F92EE;'>#TENS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17274, encryptionId=b45d1e274e8, topicName=TENS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b172500206, createdName=12498ebem19暂无昵称, createdTime=Wed Dec 04 09:14:00 CST 2019, time=2019-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1501359, encodeId=7c181501359eb, content=<a href='/topic/show?id=f2db9238f9' target=_blank style='color:#2F92EE;'>#Hypertension#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9238, encryptionId=f2db9238f9, topicName=Hypertension)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Mon Mar 11 02:14:00 CST 2019, time=2019-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1551149, encodeId=f2ec155114977, content=<a href='/topic/show?id=e2c1e230796' target=_blank style='color:#2F92EE;'>#监护#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72307, encryptionId=e2c1e230796, topicName=监护)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=477814173963, createdName=bioon6, createdTime=Mon Mar 11 02:14:00 CST 2019, time=2019-03-11, status=1, ipAttribution=)]
    2019-03-11 bioon6

相关资讯

Hypertension:幼年生活因素和血压变化轨迹与成人早期高血压有关

围生期和婴儿期的多种危险因素与高血压密切相关。近期,发表于Hypertention杂志的一项研究对生命早期相关危险因素与成年高血压的关系进行分析。

时隔14年AHA再发声明,血压测量的这些误区,可别再犯了

高血压是诱发心脏病和卒中的重要危险因素,而准确测量血压对于诊断和管理高血压至关重要!作为患者,你会测血压吗?作为医务工作者,该如何更好地指导患者测量血压?

Neurology:血压和降脂对认知的影响

由此可见,坎地沙坦加氢氯噻嗪,瑞舒伐他汀或其联合用药可以长期降低血压,但并未显著影响老年人的认知能力下降。

JAHA:外周动脉疾病患者血压越低,心血管风险越高

在外周动脉疾病患者中,高血压是一个心血管疾病的危险因素,然而这类患者的理想血压尚不清楚。本研究的目的旨在评估外周动脉疾病患者收缩压(SBP)与心血管疾病的相关性。本研究纳入了2773名患者,根据血压分为SBP≤120 mm Hg, n=604; 121–140 mm Hg, n=1065; 和 >140 mm Hg, n=1104。多元回归分析后发现与SBP在121–140 mm Hg的患者

美国心脏协会称有四种情况可隐形升高血压:测量不正确可让血压假性升高

高血压是全球疾病负担最重的慢性病之一,我国现有高血压患者2.45亿,高血压防治任务艰巨。除了生活方式调节和药物治疗,近期美国心脏协会(AHA)指出,高血压患者还要警惕日常生活中4种可隐形升高血压的情况。

Hypertension:中国成人衰老、动脉硬化和血压的关系

由此可见,动脉硬化介导了衰老与血压之间的正相关,动脉硬化可能先于血压升高。

Baidu
map
Baidu
map
Baidu
map